CSPC Pharmaceutical Group Limited (HKG: 1093)
Hong Kong
· Delayed Price · Currency is HKD
4.590
-0.040 (-0.86%)
Jan 3, 2025, 4:08 PM HKT
CSPC Pharmaceutical Group Revenue
CSPC Pharmaceutical Group had revenue of 6.40B CNY in the quarter ending September 30, 2024, a decrease of -17.76%. This brings the company's revenue in the last twelve months to 30.27B, down -3.31% year-over-year. In the year 2023, CSPC Pharmaceutical Group had annual revenue of 31.45B with 1.66% growth.
Revenue (ttm)
30.27B CNY
Revenue Growth
-3.31%
P/S Ratio
1.61
Revenue / Employee
1.29M CNY
Employees
23,500
Market Cap
52.88B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 31.45B | 513.21M | 1.66% |
Dec 31, 2022 | 30.94B | 3.07B | 11.02% |
Dec 31, 2021 | 27.87B | 2.92B | 11.73% |
Dec 31, 2020 | 24.94B | 2.84B | 12.84% |
Dec 31, 2019 | 22.10B | 4.39B | 24.76% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 26.04B |
Hansoh Pharmaceutical Group Company | 13.00B |
JD Health International | 58.84B |
WuXi Biologics | 18.39B |
Sinopharm Group | 634.32B |
Innovent Biologics | 8.01B |
Sino Biopharmaceutical | 29.86B |
Akeso | 2.01B |
CSPC Pharmaceutical Group News
- 2 months ago - CSPC Pharmaceutical Group Limited goes ex dividend tomorrow - Seeking Alpha
- 3 months ago - AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline - Benzinga
- 3 months ago - Dow Tumbles Over 400 Points; Duckhorn Portfolio Shares Surge - Benzinga
- 3 months ago - Crude Oil Gains Over 3%; Scholar Rock Shares Spike Higher - Benzinga
- 3 months ago - US Stocks Open Lower; Dow Tumbles Over 150 Points - Benzinga
- 3 months ago - AstraZeneca Inks $1.92B License Pact With Hong Kong-Based Firm To Boost Cardiovascular Pipeline - Benzinga